AngioDynamics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Thank you, everyone, for joining today. My name is [Soren Merle]. I'm an associate on the medtech team here at JPMorgan. It's my pleasure to have here on the call today, AngioDynamics' CEO, Jim Clemmer; and CFO, Stephen Trowbridge.
(Operator Instructions)
But with that, I'd like to hand it over to AngioDynamics.
Thanks, [Soren]. And thanks for the folks at JPMorgan for inviting us to the conference this year. So before I begin, let me remind investors that what you'll hear from us today are our expectations. These are forward-looking statements and most investors know of the risk and forward-looking statements. So please do your diligence, listen to what we say today. Understand, again, we can't always predict the future in an accurate manner. So do your best diligence as you look forward to invest.
So let me tell you a little bit about AngioDynamics. If you look to our slide deck, you start on Slide 3. Our company is really going through what we're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
